Assessing hemorrhagic risk in transthyretin cardiac amyloidosis. The haemorrhagic-embolic conundrum

Scritto il 08/06/2026
da Silvia Vilches

No abstract

Amyloid. 2026 Jun 8:1-4. doi: 10.1080/13506129.2026.2683425. Online ahead of print.

NO ABSTRACT

PMID:42253031 | DOI:10.1080/13506129.2026.2683425